308430 셀비온
기본 정보
- 섹터: KOSDAQ:제조
- 시가총액: 2,164억원 (2026-06-30 기준)
- 첫 등장: 2026-06-29 (누적 1일)
- 태그: 매크로/바이오헬스 · 방사성의약품 · 항암신약 · 전립선암 · CDMO · 표적치료
- 네이버 금융: 🔗
기업개요
- 동사는 2010년 방사성의약품 분야의 글로벌 리더를 목표로 설립되었으며, 2024년 코스닥시장에 기술성장기업으로 상장함.
- 신약개발, 제네릭 전문의약품, CDMO 사업을 영위하며, 특히 전립선암 치료 및 진단을 위한 Theranostics 방사성의약품 신약 개발에 주력하고 있음.
- 식약처 GMP 인증 주사제 바이알 제조 시설을 보유하고, 2018년 유럽 EMA로부터 임상용 주사제 동결건조 바이알 GMP 허가를 득하였음.
출처: 네이버증권 종목분석 (WiseReport)
일자별 등장 (최신 위, 누적)
| 일자 | 전일 종가 | 종가 | 등락률 | 시간외 | vol | 색깔 | smart | 외 | 연 | 금투 | 투 | 개 | 그외 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-14 | 14,810 | 14,800 | 🔵 -0.07% | -1.35%p | ×0.4 | 🔻 개인 | -0.3억 | -0.3 | +0.0 | +0.0 | +0.0 | +0.3 | +0.0 |
| 2026-08-13 | 14,760 | 14,810 | 🔴 +0.34% | +0.48%p | ×0.9 | 🔻 개인 | -1.6억 | -1.5 | +0.0 | +0.0 | -0.1 | +1.6 | -0.0 |
| 2026-08-12 | 14,460 | 14,760 | 🔴 +2.07% | +0.13%p | ×0.4 | 🔻 개인 | -0.4억 | -0.3 | +0.0 | -0.1 | -0.1 | +0.5 | +0.0 |
| 2026-08-11 | 14,360 | 14,460 | 🔴 +0.70% | +0.56%p | ×0.5 | 🔻 개인 | -0.2억 | -0.2 | +0.0 | +0.0 | +0.0 | +0.2 | +0.0 |
| 2026-08-10 | 13,270 | 14,360 | 🔴 +8.21% | +0.07%p | ×0.8 | 🔻 개인 | -0.2억 | -0.2 | +0.0 | +0.0 | +0.0 | +0.4 | -0.2 |
| 2026-08-07 | 13,510 | 13,270 | 🔵 -1.78% | -0.74%p | ×0.4 | 🔻 개인 | -0.4억 | -0.4 | +0.0 | +0.0 | +0.0 | +0.4 | +0.0 |
| 2026-08-06 | 13,420 | 13,510 | 🔴 +0.67% | +1.04%p | ×0.5 | 🔻 개인 | -1.0억 | -1.0 | +0.0 | +0.0 | +0.0 | +1.0 | -0.0 |
| 2026-08-05 | 13,900 | 13,420 | 🔵 -3.45% | -0.36%p | ×0.8 | 🔻 개인 | -2.3억 | -2.4 | +0.0 | +0.0 | +0.2 | +2.8 | -0.5 |
| 2026-08-04 | 12,770 | 13,900 | ➖ 🔴 +8.85% | -1.41%p | ×1.2 | 🔻 개인 | -0.5억 | -0.6 | +0.0 | -0.1 | +0.2 | +0.5 | +0.0 |
| 2026-08-03 | 12,380 | 12,770 | 🔴 +3.15% | -0.81%p | ×0.8 | 🟢 외인 | +0.7억 | +0.8 | +0.0 | -0.0 | -0.1 | -0.7 | +0.0 |
| 2026-07-31 | 10,600 | 12,380 | 🔴 +16.79% | -2.08%p | ×2.3 | 🟢 외인 | +1.2억 | +0.7 | +0.0 | -0.1 | +0.5 | -1.1 | -0.0 |
| 2026-07-30 | 10,770 | 10,600 | 🔵 -1.58% | +0.28%p | ×1.8 | 🟦 연기금 | -0.3억 | -0.6 | +0.3 | +0.0 | +0.0 | +0.3 | +0.0 |
| 2026-07-29 | 11,600 | 10,770 | 🔵 -7.16% | +1.29%p | ×1.6 | 🟢 외인 | +0.6억 | +1.1 | +0.0 | -0.0 | -0.5 | -0.7 | +0.0 |
| 2026-07-28 | 12,690 | 11,600 | 🔵 -8.59% | +0.08%p | ×1.1 | ⚫ 그외 | -0.4억 | -0.2 | +0.0 | -0.3 | -0.2 | +0.3 | +0.4 |
| 2026-07-27 | 12,670 | 12,690 | 🔴 +0.16% | +1.26%p | ×0.3 | 🔻 개인 | -0.6억 | -0.5 | +0.0 | +0.0 | -0.1 | +0.6 | +0.0 |
| 2026-07-24 | 13,000 | 12,670 | 🔵 -2.54% | -0.08%p | ×0.7 | 🔻 개인 | -1.0억 | -1.0 | +0.0 | +0.0 | +0.0 | +1.0 | +0.0 |
| 2026-07-23 | 12,340 | 13,000 | 🔴 +5.35% | -1.38%p | ×0.4 | 🟣 투신 | +0.4억 | +0.1 | +0.0 | +0.0 | +0.3 | -0.4 | +0.0 |
| 2026-07-22 | 12,260 | 12,340 | 🔴 +0.65% | +0.08%p | ×1.7 | 🟣 투신 | +1.8억 | -1.8 | +0.0 | +0.0 | +3.6 | -1.8 | +0.0 |
| 2026-07-21 | 12,270 | 12,260 | 🔵 -0.08% | +1.55%p | ×0.8 | 🟢 외인 | +0.3억 | +0.6 | +0.0 | +0.0 | -0.2 | -0.3 | -0.0 |
| 2026-07-20 | 13,190 | 12,270 | 🔵 -6.97% | +0.16%p | ×0.6 | 🔻 개인 | -0.8억 | -0.8 | +0.0 | +0.0 | -0.1 | +0.8 | +0.0 |
| 2026-07-16 | 13,310 | 13,190 | 🔵 -0.90% | -0.15%p | ×1.0 | 🟢 외인 | +0.6억 | +0.7 | +0.0 | +0.0 | -0.1 | -0.6 | +0.0 |
| 2026-07-15 | 12,900 | 13,310 | 🔴 +3.18% | -1.39%p | ×1.7 | 🔻 개인 | -0.8억 | -0.7 | +0.0 | +0.3 | -0.1 | +0.5 | +0.1 |
| 2026-07-14 | 13,370 | 12,900 | 🔵 -3.52% | +0.97%p | ×1.5 | 🟢 외인 | +1.2억 | +1.4 | +0.0 | +0.1 | -0.1 | -1.4 | +0.1 |
| 2026-07-13 | 14,910 | 13,370 | 🔵 -10.33% | -0.94%p | ×1.1 | 🔻 개인 | -1.3억 | -1.3 | +0.0 | +0.0 | +0.0 | +1.2 | +0.0 |
| 2026-07-10 | 14,520 | 14,910 | 🔴 +2.69% | -0.20%p | ×0.4 | 🟢 외인 | +0.2억 | +0.2 | +0.0 | +0.0 | +0.0 | -0.2 | +0.0 |
| 2026-07-09 | 14,680 | 14,520 | 🔵 -1.09% | +0.00%p | ×0.7 | 🟢 외인 | +1.4억 | +1.4 | +0.0 | -0.0 | +0.0 | -1.6 | +0.1 |
| 2026-07-08 | 16,010 | 14,680 | 🔵 -8.31% | -0.75%p | ×0.9 | 🟢 외인 | +0.7억 | +0.7 | +0.0 | +0.0 | +0.0 | -0.8 | +0.0 |
| 2026-07-07 | 16,480 | 16,010 | 🔵 -2.85% | +0.06%p | ×0.6 | 🔻 개인 | -0.1억 | -0.1 | +0.0 | +0.0 | +0.0 | +0.4 | -0.4 |
| 2026-07-06 | 16,960 | 16,480 | 🔵 -2.83% | -0.06%p | ×0.3 | 🔻 개인 | -0.8억 | -0.8 | +0.0 | +0.0 | +0.0 | +0.6 | +0.3 |
| 2026-07-03 | 17,060 | 16,960 | 🔵 -1.28% | -1.46%p | ×0.6 | 🔻 개인 | -0.5억 | -0.5 | +0.0 | -0.0 | +0.0 | +0.3 | +0.2 |
| 2026-07-02 | 17,520 | 17,060 | 🔵 -2.63% | -0.69%p | ×1.0 | ⚫ 그외 | -0.7억 | -0.7 | +0.0 | +0.0 | +0.0 | +0.2 | +0.5 |
| 2026-07-01 | 16,880 | 17,520 | 🔴 +3.79% | -0.36%p | ×0.5 | 🔻 개인 | -1.5억 | -1.6 | +0.0 | +0.0 | +0.1 | +1.0 | +0.5 |
| 2026-06-30 | 17,040 | 16,880 | 🔵 -0.94% | +0.64%p | ×0.5 | 🔻 개인 | -1.3억 | -1.3 | +0.0 | +0.0 | +0.0 | +0.9 | +0.4 |
| 2026-06-29 | 15,020 | 17,040 | 🔴 +13.45% | -1.13%p | ×0.8 | 🟢 외인 | +3.5억 | +3.5 | +0.0 | +0.0 | +0.0 | -3.8 | +0.3 |
| 2026-06-26 | 16,090 | 15,020 | 🔵 -6.65% | +0.75%p | ×1.3 | ⚫ 그외 | -0.4억 | -0.7 | +0.0 | +0.0 | +0.3 | -0.1 | +0.5 |
| 2026-06-25 | 16,880 | 16,090 | 🔵 -4.68% | +0.71%p | ×0.6 | 🔻 개인 | -3.5억 | -3.5 | +0.0 | +0.0 | +0.0 | +3.3 | +0.2 |
| 2026-06-24 | 15,870 | 16,880 | 🔴 +6.36% | +1.00%p | ×1.1 | 🟣 투신 | +1.6억 | -0.9 | +0.0 | +0.0 | +2.5 | -1.4 | -0.1 |
| 2026-06-23 | 16,500 | 15,870 | 🔵 -3.82% | -1.40%p | ×0.9 | 🔻 개인 | +0.3억 | +0.4 | -0.0 | +0.0 | +0.7 | -1.1 | |
| 2026-06-22 | 16,950 | 16,500 | 🔵 -2.65% | +0.00%p | ×0.7 | 🔻 개인 | -0.9억 | -0.9 | +0.0 | +0.0 | +0.8 | +0.1 | |
| 2026-06-19 | 17,530 | 16,950 | 🔵 -3.31% | +0.74%p | ×1.4 | 🟢 외인 | +0.9억 | +0.9 | +0.0 | +0.0 | +0.2 | -1.1 | |
| 2026-06-18 | 18,630 | 17,530 | 🔵 -5.90% | -0.91%p | ×1.2 | 🔻 개인 | -2.4억 | -2.4 | +0.0 | +0.0 | +2.9 | -0.6 | |
| 2026-06-17 | 18,180 | 18,630 | 🔴 +2.48% | +0.22%p | ×0.8 | ⚫ 그외 | -0.8억 | -0.8 | -0.0 | -0.0 | -1.0 | +1.9 | |
| 2026-06-16 | 18,180 | 18,180 | ⚪ +0.00% | +1.10%p | ×0.5 | ⚫ 그외 | -0.6억 | -0.6 | +0.0 | +0.2 | -1.2 | +1.5 | |
| 2026-06-15 | 18,540 | 18,180 | 🔵 -1.94% | +0.70%p | ×0.5 | 🔻 개인 | -3.1억 | -3.1 | +0.0 | +0.4 | +2.8 | -0.0 | |
| 2026-06-12 | 17,960 | 18,540 | 🔴 +3.23% | +1.28%p | ×0.5 | 🟦 연기금 | +1.6억 | -1.1 | +2.8 | +0.0 | -1.6 | -0.0 | |
| 2026-06-11 | 17,440 | 17,960 | 🔴 +2.98% | +0.97%p | ×0.5 | ⚫ 그외 | -1.5억 | -1.5 | +0.0 | -0.0 | -0.0 | +1.5 | |
| 2026-06-10 | 17,980 | 17,440 | 🔵 -3.00% | -1.33%p | ×0.3 | 🔻 개인 | -2.3억 | -2.3 | +0.0 | +0.0 | +1.8 | +0.5 | |
| 2026-06-09 | 17,190 | 17,980 | 🔴 +4.60% | +0.30%p | ×0.6 | 🔻 개인 | -1.6억 | -1.6 | -0.0 | +0.0 | +0.8 | +0.8 | |
| 2026-06-08 | 19,220 | 17,190 | 🔵 -10.56% | -1.61%p | ×0.5 | 🟢 외인 | +1.0억 | +1.0 | +0.0 | +0.0 | -0.3 | -0.7 | |
| 2026-06-05 | 18,960 | 19,220 | 🔴 +1.37% | +0.26%p | ×0.4 | 🟢 외인 | +0.6억 | +0.6 | +0.0 | +0.0 | -1.1 | +0.5 | |
| 2026-06-04 | 19,140 | 18,960 | 🔵 -0.94% | -1.10%p | ×0.7 | 🟢 외인 | +2.8억 | +2.8 | +0.0 | +0.0 | -3.6 | +0.8 | |
| 2026-06-02 | 19,990 | 19,140 | 🔵 -4.25% | -1.30%p | ×0.6 | 🟢 외인 | +5.7억 | +5.7 | +0.0 | +0.0 | -6.1 | +0.4 | |
| 2026-06-01 | 21,250 | 19,990 | 🔵 -5.93% | -0.99%p | ×1.2 | 🟢 외인 | +6.3억 | +6.3 | +0.0 | +0.0 | -6.0 | -0.3 | |
| 2026-05-29 | 22,450 | 21,250 | 🔵 -5.35% | -1.12%p | ×1.0 | 🟢 외인 | +4.1억 | +4.1 | +0.0 | -0.0 | -2.7 | -1.4 | |
| 2026-05-28 | 23,350 | 22,450 | 🔵 -3.85% | -0.42%p | ×0.6 | ⚫ 그외 | +1.8억 | +1.8 | +0.0 | +0.0 | -4.9 | +3.1 | |
| 2026-05-27 | 23,250 | 23,350 | 🔴 +0.43% | +0.21%p | ×1.1 | 🟢 외인 | +7.8억 | +7.8 | +0.0 | -0.0 | -10.4 | +2.6 | |
| 2026-05-26 | 23,950 | 23,250 | 🔵 -2.92% | -1.67%p | ×0.9 | ⚫ 그외 | -5.2억 | -5.2 | +0.0 | -0.1 | +1.5 | +3.8 | |
| 2026-05-22 | 27,300 | 23,950 | 🔵 -12.27% | +1.65%p | ×2.6 | 🔻 개인 | -19.9억 | -19.9 | +0.0 | -0.2 | +19.3 | +0.8 |
일자별 사유 (최신 위)
2026-08-04
- 사유: 머크 키트루다 병용임상 모멘텀 지속
- 섹터 컨텍스트: KOSDAQ:제조 (smart -1,616억)
- 매크로 원인: 코스닥 6%대 급반등 속 경영진 자사주 매입·임상데이터·기술이전 호재로 바이오 전반 강세 (보통)
2026-07-31
- 사유: —
- 섹터 컨텍스트: KOSDAQ:제조 (smart +2,319억)
- 매크로 원인: 하반기 신약 임상·기술이전 기대감에 바이오 투자심리 회복, 개별 이슈 뒤섞인 종목별 급등 (보통)
2026-06-29
- 사유: —
- 섹터 컨텍스트: KOSDAQ:제조 (smart +305억)
- 매크로 원인: 반도체 쏠림 차익실현 후 제약·바이오로 순환매 유입 + 국민성장펀드 기대·바이오USA 훈풍에 동반 급등 (보통)